6 Undervalued Insurance Stocks for Tuesday, August 25
Discover the top 6 undervalued Insurance stocks for Tuesday, August 25 based on AAII’s Stock Grades.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Commentary & Analysis
Which Is a Better Investment, Globe Life Inc. or Marsh & McLennan Companies, Inc. Stock?
Learn more about whether Globe Life Inc. or Marsh & McLennan Companies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Is Globe Life Inc. (GL) Overvalued?
We dive into why Globe Life Inc. (GL) could be considered overvalued on 2026-07-22, based on AAII’s Value Score and Grade.Michael Rose
Why Globe Life Inc.’s (GL) Stock Is Down 7.41%
As of Thursday, July 23, Globe Life Inc.’s GL share price has dipped by 7.41%, which has investors questioning if this is right time to buy.Jenna Brashear
What You Need to Know About Globe Life Inc.'s Q3 Earnings
Globe Life Inc.'s fiscal Q3 earnings report was released on Wednesday, July 22. Let's dive in to see if (GL) missed or beat analyst's expectations.Michael Rose
Financial Summary
| Share Statistics | GL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $12,778.5 | $5,494.5 | 81% |
|
| Shares Out (Mil) | 78.9 | 77.9 | 57% |
|
| Institutional Ownership | 99.0% | 79.9% | 84% |
|
| Float (Mil) | 76.1 | 68.1 | 56% |
|
| Beta | 0.47 | 0.49 | 27% |
|
| Avg Daily Volume (000s) | 529 | 262 | 58% |
|
| Price Change (52-week) |
20.9% | 86.6% | 70% |
|
| Growth | GL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 4.8% | 5.5% | 36% |
|
| Net Income (5yr) | 9.7% | 14.2% | 55% |
|
| EPS (5yr) | 15.6% | 15.5% | 59 |
|
| Dividends (5yr) | 7.6% | 3.8% | 82% |
|
| Cash Flow (5yr) | (27.6%) | (13.3%) | 22% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 9 | 11 | 11 | |
| Current EPS | $4.896 | $15.709 | $16.510 | |
| Month Ago EPS | $4.897 | $15.710 | $16.518 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $4.700 | $15.650 | $16.646 | |
| Year/Year Chg | 34.1% | 11.6% | 26.9% | |
| Financials | GL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6,192 | $4,725 | 77% |
|
| Net Income (TTM) (Mil) | $1,212 | $553 | 88% |
|
| EPS (TTM) | $15.341 | $2.500 | 97% |
|
| Operating Cash Flow (TTM) (Mil) | $1,392 | $562 | 85% |
|
| Net Cash Flow (TTM) (Mil) | $18 | $5 | 61% |
|
| Long-Term Debt (Q1) (Mil) | $3,149 | $880 | 80% |
|
| Enterprise Value (Q1) (Mil) | $17,299 | $7,271 | 82% |
|
| Valuation | GL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.08 | 1.52 | 54% |
|
| P/E | 11.0 | 11.5 | 22% |
|
| Dividend Yield | 0.8% | 1.2% | 65% |
|
| PEG (5yr hist) | 0.7 | 0.5 | 36% |
|
| Ratios | GL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 33.9% | 35.3% | 41% |
|
| Net Margin | 19.6% | 10.4% | 78% |
|
| ROA | 4.0% | 2.7% | 67% |
|
| ROE | 20.9% | 14.6% | 80% |
|
| Liabilities to Assets | 80.5% | 77.0% | 75% |
|
| F-Score | 7 | 6 | 82% |
|
Passing Stock Screens
As of 10/6/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Graham--Defensive Investor (Utility) Screen
Factors: Yield, Value, Quality, Industry/Sector
Graham's approach leads to three separate screens that focus on the concept of intrinsic value, justified by a firm's financial strength.
| Performance Since Inception: | 6.7% |
| +/- S&P 500: | -0.8 |
